About Us
Scientific Leadership
The MRF’s Scientific Leadership is comprised of multidisciplinary experts in basic and translational research, dermatology, epidemiology, genomics, pathology, surgery and medical oncology. Membership includes representatives from the private and public sector.
MRF Scientific Advisory Committee
CO-CHAIRS
Michael B. Atkins, MD
Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center
Georgetown University
Washington, D.C.
Glenn Merlino, PhD
Senior Investigator
Laboratory of Cancer Biology and Genetics
Scientific Director for Basic Research
Center for Cancer Research
National Cancer Institute, NIH
Bethesda, Maryland
MEMBERS
Andrew Aplin, PhD
Thomas Jefferson University
Philadelphia, PA
Menashe Bar-Eli, PhD
University of Texas
Houston, TX
Marcus Bosenberg, MD, PhD
Yale Cancer Center
New Haven, CT
Clara Curiel, MD
The University of Arizona Cancer Center
Tucson, AZ
Adil Daud, MD
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, CA
Keith T. Flaherty, MD
Massachusetts General Hospital
Boston, MA
Alan Geller, MPH, RN
Harvard School of Public Health
Boston, MA
Teresa Landi, MD, PhD
National Cancer Institute
Bethesda, MD
Martin McMahon, PhD
Huntsman Cancer Institute & Dept. of Dermatology
Salt Lake City, UT
Ze’ev A. Ronai, PhD
Sanford Burnham Prebys Medical Discovery Institute
La Jolla, CA
Keiran Smalley, PhD (Grant SRO)
H. Lee Moffitt Cancer Center & Research Institute
Tampa, FL
Jeff Sosman, MD
Robert H. Laurie Comprehensive Cancer Center of Northwestern University
Chicago, IL
Jennifer Wargo, MD, MMSc
University of Texas MD Anderson Cancer Center
Houston, TX
Ashani Weeraratna, PhD
Johns Hopkins Bloomberg School of Public Health
Baltimore, MD
MRF Breakthrough Consortium Steering Committee
CO-CHAIRS
Michael B. Atkins, MD
Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center
Georgetown University
Washington, D.C.
Keith T. Flaherty, MD
Director, Developmental Therapeutics
Massachusetts General Hospital
Boston, Massachusetts
MEMBERS
Jeffrey E. Gershenwald, MD
University of Texas, MD Anderson Cancer Center
Houston, TX
Anthony T. Hendrickson
Board of Directors, Melanoma Research Foundation
Saratoga, CA
Meenhard Herlyn, DVM, DSc
The Wistar Institute
Philadelphia, PA
Alison Martin, MD
Board of Directors, MRF
Washington, D.C.
Ze’ev A. Ronai, PhD
Sanford Burnham Medical Research Institute
La Jolla, CA
Lynn Schuchter, MD
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, PA
Steve Silverstein
Chair, Board of Directors, MRF
Woodcliff Lake, NJ
CURE OM Scientific Steering Committee
CO-CHAIRS
Keith T. Flaherty, MD
Associate Professor of Medicine, Harvard Medical School
Director of Developmental Therapeutics
Massachusetts General Hospital Cancer Center
Boston, Massachusetts
J. William Harbour, MD
Professor and Vice Chairman of Opthalmology
Bascom Palmer Eye Institute
University of Miami School of Medicine
Miami, Florida
MEMBERS
Laurence Desjardins, MD
Curie Institute
Paris, France
Elizabeth A. Grimm, PhD
University of Texas, MD Anderson Cancer Center
Houston, TX
Hans E. Grossniklaus, MD
Emory University School of Medicine
Atlanta, GA
F. Stephen Hodi, Jr, MD
Dana-Farber Cancer Institute Harvard Medical School
Boston, MA
Jacob Pe’er, MD
Hadassah Hebrew University Medical Center
Jerusalem, Israel
James F. Pingpank, Jr, MD, FACS
University of Pittsburgh
Pittsburgh, PA
Takami Sato, MD, PhD
Thomas Jefferson University
Philadelphia, PA
Dirk Schadendorf, MD
University Hospital Essen
Essen, Germany
Sara M. Selig, MD
Brigham and Women’s Hospital
Boston, MA
Stefan Seregard, MD, PhD
St. Eriks Eye Hospital
Stockholm, Sweden
Carol L. Shields, MD
Wills Eye Institute Professor of Ophthalmology, Thomas Jefferson University Hospital
Philadelphia, PA
Dirk Schadendorf, MD, Michael J. Weber, PhD
University of Virginia Cancer Center
Charlottesville, VA
David J. Wilson, MD
Oregon Health and Science University
Portland, OR
Pediatric Scientific Steering Committee
Robin Gheris, MD
Children’s Hospital of Pittsburgh
Pittsburgh, PA
Cynthia Herzog, MD
MD Anderson Cancer Center
Houston, TX
Jane Messina, MD
H. Lee Moffitt Cancer Center
Tampa, FL
Alberto Pappo, MD
St. Jude Children’s Research Hospital
Memphis, TN
Krista Rubin, NP
Massachusetts General Hospital & Children’s Melanoma Prevention Foundation
Boston, MA
Brittani Seynnaeve, MD
Children’s Hospital of Pittsburgh
Pittsburgh, PA
Vernon Sondak, MD
H. Lee Moffitt Cancer Center
Tampa, FL
Mucosal Scientific Steering Committee
Richard Carvajal, MD
Columbia University
New York City, NY
Alex Shoushtari, MD
Memorial Sloan Kettering Cancer Center
New York City, NY
Sapna Patel, MD
MD Anderson Cancer Center
Houston, TX
Marlana Orloff, MD
Thomas Jefferson University
Philadelphia, PA